BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Celtic Pharma 

Wessex House
45 Reid Street, 4th Floor
Hamilton    HM 12  Bermuda
Phone: 44-0-207-2915400 Fax: n/a


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Celtic Pharma Welcomes the Results of the Sale Process of Inspiration Biopharmaceuticals' Hemophilia Assets to Cangene Corporation (CC:CNJ) 2/7/2013 9:47:32 AM    More...
Celtic Pharma: Data from New Drug Trial Offers Prospect for Enhanced Quality of Life for Children With Late Stage Brain Tumors 6/27/2012 9:19:36 AM    More...
Celtic Pharma Announces Completion of Enrollment in Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary and Metastatic Brain Tumors 10/3/2011 11:46:36 AM    More...
Celtic Pharma Announces Presentation of Preclinical Data at the 69th Annual Meeting of the American Academy of Dermatology in New Orleans 2/7/2011 6:47:51 AM    More...
Celtic Pharma Announces Issuance of U.S. Patent 7,816,323 for Xerecept(R) in Combination with Avastin(R) as a Treatment for Breast and Colon Cancers 10/21/2010 7:36:39 AM    More...
Celtic Pharma Announces Initiation of Phase III Trial of TDT 067 for the Treatment of Onychomycosis 4/30/2010 10:49:16 AM    More...
Celtic Pharma Announces Preclinical Findings that XERECEPT(R) Potentiates Significantly the Tumor Inhibition Activity of Avastin(R) 4/19/2010 8:15:08 AM    More...
Celtic Pharma And PolyTherics Announce Investment Into Novel Biopharmaceutical Programme 1/26/2010 12:44:13 PM    More...
Celtic Pharma Announces Strategic Partnership Between Ipsen and Inspiration Biopharmaceuticals; Ipsen to Provide up to $259 Million of Funding to Inspiration 1/21/2010 6:54:37 AM    More...
Celtic Pharma Announces Investment in Novacta Biosystems 7/6/2009 9:48:13 AM    More...
12345